Neuroleptic malignant syndrome and atypical antipsychotic drugs.

@article{Ananth2004NeurolepticMS,
  title={Neuroleptic malignant syndrome and atypical antipsychotic drugs.},
  author={J. Ananth and S. Parameswaran and S. Gunatilake and K. Burgoyne and Taghrid Sidhom},
  journal={The Journal of clinical psychiatry},
  year={2004},
  volume={65 4},
  pages={
          464-70
        }
}
  • J. Ananth, S. Parameswaran, +2 authors Taghrid Sidhom
  • Published 2004
  • Medicine
  • The Journal of clinical psychiatry
    • OBJECTIVE The incidence of neuroleptic malignant syndrome (NMS) is not known, but the frequency of its occurrence with conventional antipsychotic agents has been reported to vary from 0.02% to 2.44%. DATA SOURCES MEDLINE search conducted in January 2003 and review of references within the retrieved articles. DATA SYNTHESIS Our MEDLINE research yielded 68 cases (21 females and 47 males) of NMS associated with atypical antipsychotic drugs (clozapine, N = 21; risperidone, N = 23; olanzapine, N… CONTINUE READING
    View PDF
    222 Citations
    Highly Influential Citations
    12
    Background Citations
    65
    Methods Citations
    1
    Results Citations
    4
    222 Citations
    Citation Type

    Citation Type

    Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs
    • 129
    Clozapine-induced neuroleptic malignant syndrome in an adolescent.
    • K. Matheson, G. Gray
    • Psychology, Medicine
    • Journal of child and adolescent psychopharmacology
    • 2012
    • 3
    • Highly Influenced
    Neuroleptic Malignant Syndrome, with Attention to Its Occurrence with Atypical Antipsychotic Medication: A Review
    • 12
    • Highly Influenced
    • PDF
    Neuroleptic malignant syndrome induced by low dose aripiprazole in first episode psychosis.
    • 6
    Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics
    • 59
    • PDF
    Olanzapine-Induced Neuroleptic Malignant Syndrome
    • 3
    Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?
    • 34
    • PDF
    Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
    • 58
    • PDF
    Is Neuroleptic Malignant Syndrome Diagnostic Criteria Adequately Sensitive to Identify Diverse Features of the Syndrome
    • 1
    • PDF
    Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis
    • 86
    • PDF

    References

    SHOWING 1-10 OF 79 REFERENCES
    Clozapine-Associated Neuroleptic Malignant Syndrome: Two New Cases and a Review of the Literature
    • 106
    Risperidone-Induced Neuroleptic Malignant Syndrome: A Case Report and Review
    • G. Meterissian
    • Psychology, Medicine
    • Canadian journal of psychiatry. Revue canadienne de psychiatrie
    • 1996
    • 31
    Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.
    • 35
    Neuroleptic malignant syndrome associated with clozapine treatment.
    • 37
    Neuroleptic Malignant Syndrome during a Change from Haloperidol to Risperidone
    • 17
    Risperidone and neuroleptic malignant syndrome.
    • 18
    Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.
    • 133
    Neuroleptic Malignant Syndrome Associated with Quetiapine
    • 11
    Olanzapine usage associated with neuroleptic malignant syndrome.
    • 26
    Clinical Management of Neuroleptic Malignant Syndrome
    • 83